Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5258]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Challenges and solutions in PD-L1 testing in NSCLC
Prof Frédérique Penault-Llorca - Centre Jean Perrin, Clermont-Ferrand, France
Challenges and solutions in PD-L1 testing in NSCLC ( Prof Frédérique Penault-Llorca - Centre Jean Perrin, Clermont-Ferrand, France )
5 Mar 2021
Promise of personalised medicine for patients with prostate cancer
Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt...
Promise of personalised medicine for patients with prostate cancer ( Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt Attard )
26 Feb 2021
Latest developments in the treatment of mRCC
Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald
Latest developments in the treatment of mRCC ( Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald )
24 Feb 2021
Long term response to apalutamide and other updates impacting patients with...
Prof Axel Merseburger and Prof Matthew Smith
Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU 2021 ( Prof Axel Merseburger and Prof Matthew Smith )
22 Feb 2021
mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early...
Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt...
mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early treatment? ( Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt Attard )
19 Feb 2021
Current treatment standards for primary ovarian cancer
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Current treatment standards for primary ovarian cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021
Evolving medical treatment in advanced/recurrent endometrial cancer
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Evolving medical treatment in advanced/recurrent endometrial cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021
Nurse's perspective on PARP inhibitors and personalised medicine in prostate...
Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK
Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )
17 Feb 2021
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair...
Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )
15 Feb 2021
TITAN: Update and where next for patients with hormone sensitive PC
Prof Axel Merseburger and Prof Kim Chi
TITAN: Update and where next for patients with hormone sensitive PC ( Prof Axel Merseburger and Prof Kim Chi )
15 Feb 2021
OncoAlert and ecancer weekly roundup for February 07 - 13, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for February 07 - 13, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
15 Feb 2021
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
9 Feb 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation